UK-116044-04 |
UK-116044-04 [AS HYDROBROMIDE) |
RELPAX |
UK-116044 |
ELETRIPTAN |
UK-116,044-04 FREE BASE |
UK-116044-04 FREE BASE |
UK 116044 |
ELETRIPTANUM |
RELPAX® |
chembl:CHEMBL1510 |
drugbank:00216 |
chemidplus:143322-58-1 |
rxcui:231049 |
pubchem.compound:77993 |
FDA Approval | approved |
Drug Indications | antimigraine agent |
Drug Class | Small Molecule |
Drug Class | anti-migraine agents |
Year of Approval | 2002 |
Drug Categories | triptans |
Drug Categories | agents that produce hypertension |
Drug Categories | antidepressive agents |
Drug Categories | central nervous system depressants |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 enzyme inducers |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | heterocyclic compounds, fused-ring |
Drug Categories | p-glycoprotein substrates |
Drug Categories | selective serotonin 5-ht1 receptor agonists |
Drug Categories | selective serotonin agonists |
Drug Categories | serotonergic drugs shown to increase risk of serotonin syndrome |
Drug Categories | serotonin 1b receptor agonists |
Drug Categories | serotonin 1d receptor agonists |
Drug Categories | serotonin-1b and serotonin-1d receptor agonist |
agonist (activating) |
Specific Action of the Ligand | Full agonist |
Endogenous Drug? | False |
Direct Interaction? | True |
agonist (activating) |
Endogenous Drug? | False |
Specific Action of the Ligand | Full agonist |
agonist (activating) |
Endogenous Drug? | False |
Specific Action of the Ligand | Full agonist |
ELETRIPTAN | DrugBank Drug Name |
143322-58-1 | CAS Number |
Apo-eletriptan | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | investigational |
ELETRIPTAN | Primary Drug Name |
Year of Approval | 2002 |
Drug Class | anti-migraine agents |
Drug Class | Small Molecule |
Drug Indications | antimigraine agent |
FDA Approval | approved |
D02DMQ | TTD Drug ID |
ELETRIPTAN | GuideToPharmacology Ligand Name |